Direct coupling of the cell cycle and cell death machinery by E2F (original) (raw)
Evan, G. I. & Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature411, 342–348 (2001). ArticleCASPubMed Google Scholar
Sherr, C. J. The INK4a/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol.2, 731–737 (2001). ArticleCAS Google Scholar
Trimarchi, J. M. & Lees, J. A. Sibling rivalry in the E2F family. Nature Rev. Mol. Cell Biol.3, 11–20 (2002). ArticleCAS Google Scholar
Tolbert, D., Lu, X., Yin, C., Tantama, M. & Van Dyke, T. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumour suppression in vivo. Mol. Cell. Biol.22, 370–377 (2002). ArticleCASPubMedPubMed Central Google Scholar
Tsai, K. Y. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell2, 293–304 (1998). ArticleCASPubMed Google Scholar
Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R. & Vousden, K. H. E2F-1 potentiates cell death by blocking anti-apoptotic signalling pathways. Mol. Cell4, 771–781 (1999). ArticleCASPubMed Google Scholar
Irwin, M. et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature407, 645–648 (2000). ArticleCASPubMed Google Scholar
Stiewe, T. & Putzer, B. M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nature Genet.26, 464–469 (2000). ArticleCASPubMed Google Scholar
Soengas, M. S. et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumour inhibition. Science284, 156–159 (1999). ArticleCASPubMed Google Scholar
Moroni, M. C. et al. Apaf-1 is a transcriptional target for E2F and p53. Nature Cell Biol.3, 552–558 (2001). ArticleCASPubMed Google Scholar
Robles, A. I., Bemmels, N. A., Foraker, A. B. & Harris, C. C. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res.61, 6660–6664 (2001). CASPubMed Google Scholar
Samuelson, A. V. & Lowe, S. W. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl Acad. Sci. USA94, 12094–12099 (1997). ArticleCASPubMedPubMed Central Google Scholar
Vigo, E. et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol.19, 6379–6395 (1999). ArticleCASPubMedPubMed Central Google Scholar
Muller, H. et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation and apoptosis. Genes Dev.15, 267–285 (2001). ArticleCASPubMedPubMed Central Google Scholar
Kel, A. E. et al. Computer-assisted identification of cell cycle-related genes: New targets for E2F transcription factors. J. Mol. Biol.309, 99–120 (2001). ArticleCASPubMed Google Scholar
Takahashi, Y., Rayman, J. B. & Dynlacht, B. D. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev.14, 804–816 (2000). CASPubMedPubMed Central Google Scholar
Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell94, 339–352 (1998). ArticleCASPubMed Google Scholar
Varfolomeev, E. E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity9, 267–276 (1998). ArticleCASPubMed Google Scholar
McCurrach, M. E., Connor, T. M., Knudson, C. M., Korsmeyer, S. J. & Lowe, S. W. _bax_-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl Acad. Sci. USA94, 2345–2349 (1997). ArticleCASPubMedPubMed Central Google Scholar
Narita, M. et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl Acad. Sci. USA95, 14681–14686 (1998). ArticleCASPubMedPubMed Central Google Scholar
Yang, X., Chang, H. Y. & Baltimore, D. Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell1, 319–325 (1998). ArticleCASPubMed Google Scholar
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S. & Dixit, V. M. An induced proximity model for caspase-8 activation. J. Biol. Chem.273, 2926–2930 (1998). ArticleCASPubMed Google Scholar
Routes, J. M. et al. Adenovirus E1A oncogene expression in tumour cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol.165, 4522–4527 (2000). ArticleCASPubMed Google Scholar
Lin, A. W. & Lowe, S. W. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl Acad. Sci. USA98, 5025–5030 (2001). ArticleCASPubMedPubMed Central Google Scholar
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell88, 593–602 (1997). ArticleCASPubMed Google Scholar
Schwarz, J. K. et al. Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression. Proc. Natl Acad. Sci. USA92, 483–487 (1995). ArticleCASPubMedPubMed Central Google Scholar
Harlow, E., Franza, B. R. & Schley, C. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J. Virol.55, 533–546 (1985). CASPubMedPubMed Central Google Scholar